Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sandostatin (octreotide acetate).

D Claussen

    Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
    |December 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Sandostatin effectively manages symptoms in patients with metastatic neuroendocrine tumors and controls pancreatic activity post-procedure. Regular monitoring of electrolytes, glucose, and thyroid function is crucial during Sandostatin therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Malignant hyperthermia and sevoflurane--a case report].

    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·1998
    Same author

    [O2 administration and O2 monitoring in jet ventilation].

    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·1996
    Same author

    [Pituitary crisis and acute renal failure--a case report].

    Anaesthesiologie und Reanimation·1994
    Same author

    Droperidol (Inapsine).

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·1992
    Same author

    Asacol (mesalamine).

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·1992
    Same author

    Professional practice in the 1990s.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·1992
    Same journal

    The Public Trust in Nursing: Is It Waning?

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Budd-Chiari Syndrome Due to Protein C Deficiency: A Case Report.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Lead Time and Tailored Messaging Promote Early-Onset Colorectal Cancer Prevention and Screening.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Minimum Registered Nurse Staffing for Patient Care in the Gastroenterology/Endoscopy Setting.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Ergonomic Considerations in ERCP Practice.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    Same journal

    Factors Associated With Intention to Undergo Colonoscopy Reexamination Based on Pender's Health Promotion Model: A Cross-Sectional Study.

    Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates·2026
    See all related articles

    Area of Science:

    • Oncology
    • Endocrinology
    • Gastroenterology

    Background:

    • Sandostatin (octreotide) is an antineoplastic drug.
    • It is utilized for managing metastatic carcinoid tumors and vasoactive intestinal peptide-secreting tumors.
    • Sandostatin also addresses hypotension and acromegaly, and pancreatic motility post-ERCP.

    Purpose of the Study:

    • To summarize the therapeutic applications of Sandostatin.
    • To highlight the importance of monitoring during Sandostatin therapy.
    • To inform about potential side effects and management strategies.

    Main Methods:

    • Literature review of Sandostatin's clinical uses.
    • Analysis of reported side effects and management protocols.
    • Identification of necessary monitoring parameters for chronic therapy.

    Related Experiment Videos

    Main Results:

    • Sandostatin is effective in controlling diarrhea and hypokalemia in specific tumor types.
    • It has demonstrated efficacy in treating hypotension and acromegaly.
    • Sandostatin reduces pancreatic motility after endoscopic retrograde cholangiopancreatography.

    Conclusions:

    • Sandostatin is a versatile drug with multiple therapeutic indications.
    • Side effects are generally rare and manageable.
    • Chronic Sandostatin use requires vigilant monitoring of metabolic and endocrine functions, including electrolytes, glucose, and thyroid status, along with potential impacts on fat absorption and gallbladder function.